Operaciones Savara - SVRA CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.07 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.024874% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.002651% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Cierre previo* | 1.99 |
Abrir* | 1.98 |
Cambio de 1 año* | 59.68% |
Rango del día* | 1.83 - 1.99 |
Rango de 52 semanas | 1.06-2.85 |
Volumen medio (10 días) | 109.97K |
Volumen medio (3 meses) | 5.23M |
Capitalización de mercado | 222.39M |
Ratio P/E | -100.00K |
Acciones en circulación | 114.07M |
Ingresos | N/A |
EPS | -0.27 |
Dividendo (Rendimiento %) | N/A |
Beta | 0.86 |
Próxima fecha de resultados | May 9, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
Mar 31, 2023 | 1.91 | -0.07 | -3.54% | 1.98 | 1.99 | 1.80 |
Mar 30, 2023 | 1.99 | 0.01 | 0.51% | 1.98 | 2.05 | 1.98 |
Mar 29, 2023 | 2.00 | 0.04 | 2.04% | 1.96 | 2.00 | 1.93 |
Mar 28, 2023 | 2.00 | 0.04 | 2.04% | 1.96 | 2.04 | 1.92 |
Mar 27, 2023 | 1.99 | 0.02 | 1.02% | 1.97 | 2.06 | 1.97 |
Mar 24, 2023 | 1.96 | 0.10 | 5.38% | 1.86 | 2.02 | 1.86 |
Mar 23, 2023 | 1.91 | 0.09 | 4.95% | 1.82 | 2.02 | 1.82 |
Mar 22, 2023 | 1.88 | -0.02 | -1.05% | 1.90 | 1.94 | 1.80 |
Mar 21, 2023 | 1.95 | -0.12 | -5.80% | 2.07 | 2.08 | 1.91 |
Mar 20, 2023 | 2.03 | 0.04 | 2.01% | 1.99 | 2.08 | 1.98 |
Mar 17, 2023 | 2.00 | -0.01 | -0.50% | 2.01 | 2.11 | 1.96 |
Mar 16, 2023 | 2.14 | 0.13 | 6.47% | 2.01 | 2.22 | 2.01 |
Mar 15, 2023 | 2.17 | 0.03 | 1.40% | 2.14 | 2.23 | 2.11 |
Mar 14, 2023 | 2.17 | 0.13 | 6.37% | 2.04 | 2.28 | 2.04 |
Mar 13, 2023 | 2.08 | 0.10 | 5.05% | 1.98 | 2.21 | 1.95 |
Mar 10, 2023 | 2.08 | -0.31 | -12.97% | 2.39 | 2.41 | 1.96 |
Mar 9, 2023 | 2.46 | 0.04 | 1.65% | 2.42 | 2.48 | 2.41 |
Mar 8, 2023 | 2.48 | 0.13 | 5.53% | 2.35 | 2.48 | 2.33 |
Mar 7, 2023 | 2.43 | 0.01 | 0.41% | 2.42 | 2.48 | 2.41 |
Mar 6, 2023 | 2.41 | 0.12 | 5.24% | 2.29 | 2.44 | 2.29 |
Savara Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
No events scheduled |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Ingresos totales | 0 | 0.257 | 0 | 0 | 0 |
Ingresos | 0 | 0.257 | 0 | ||
Gastos totales de explotación | 41.477 | 49.557 | 79.025 | 70.045 | 31.772 |
Gastos de venta/general/administración Gastos, total | 12.35 | 14.264 | 13.081 | 10.654 | 8.881 |
Investigación y desarrollo | 28.991 | 35.038 | 38.781 | 37.173 | 18.512 |
Depreciation / Amortization | 0.136 | 0.255 | 0.311 | 0.526 | 0.363 |
Gastos (ingresos) extraordinarios | 0 | 26.852 | 21.692 | 4.016 | |
Ingresos de explotación | -41.477 | -49.3 | -79.025 | -70.045 | -31.772 |
Ingresos por intereses (gastos), netos No operativos | -2.381 | -1.208 | -0.361 | 0.018 | -1.659 |
Otros, netos | 0.844 | 0.893 | 1.213 | 1.454 | |
Ingresos netos antes de impuestos | -43.014 | -49.615 | -78.173 | -68.573 | -33.431 |
Ingresos netos después de impuestos | -43.014 | -49.615 | -78.173 | -61.516 | -32.597 |
Beneficio neto antes de partidas extra. Elementos | -43.014 | -49.615 | -78.173 | -61.516 | -32.597 |
Ingresos netos | -43.014 | -49.615 | -78.173 | -61.516 | -29.797 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -43.014 | -49.615 | -78.173 | -61.516 | -33.579 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -43.014 | -49.615 | -78.173 | -61.516 | -30.779 |
Beneficio neto diluido | -43.014 | -49.615 | -78.173 | -61.516 | -30.779 |
Promedio ponderado de acciones diluidas | 133.919 | 59.3091 | 40.0278 | 33.3007 | 17.5211 |
BPA diluido sin partidas extraordinarias | -0.32119 | -0.83655 | -1.95297 | -1.84729 | -1.91649 |
BPA normalizado diluido | -0.17185 | -0.83655 | -1.28214 | -1.19589 | -1.7675 |
Total de partidas extraordinarias | 2.8 | ||||
Total Adjustments to Net Income | -0.982 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Ingresos totales | 0 | 0 | 0 | 0 | 0 |
Gastos totales de explotación | 10.535 | 9.383 | 8.046 | 10.639 | 9.972 |
Gastos de venta/general/administración Gastos, total | 2.376 | 2.957 | 2.354 | 3.019 | 3.4 |
Investigación y desarrollo | 8.151 | 6.418 | 5.684 | 7.618 | 6.532 |
Depreciation / Amortization | 0.008 | 0.008 | 0.008 | 0.002 | 0.04 |
Ingresos de explotación | -10.535 | -9.383 | -8.046 | -10.639 | -9.972 |
Ingresos por intereses (gastos), netos No operativos | 0.144 | -0.242 | -0.583 | -0.642 | -0.574 |
Otros, netos | 0.005 | 0.461 | 0.329 | -0.029 | 0 |
Ingresos netos antes de impuestos | -10.386 | -9.164 | -8.3 | -11.31 | -10.546 |
Ingresos netos después de impuestos | -10.386 | -9.164 | -8.3 | -11.31 | -10.546 |
Beneficio neto antes de partidas extra. Elementos | -10.386 | -9.164 | -8.3 | -11.31 | -10.546 |
Ingresos netos | -10.386 | -9.164 | -8.3 | -11.31 | -10.546 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -10.386 | -9.164 | -8.3 | -11.31 | -10.546 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -10.386 | -9.164 | -8.3 | -11.31 | -10.546 |
Beneficio neto diluido | -10.386 | -9.164 | -8.3 | -11.31 | -10.546 |
Promedio ponderado de acciones diluidas | 152.773 | 152.771 | 152.769 | 133.919 | 152.588 |
BPA diluido sin partidas extraordinarias | -0.06798 | -0.05999 | -0.05433 | -0.08445 | -0.06911 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.06798 | -0.05999 | -0.05433 | 0.06489 | -0.06911 |
Ingresos | 0 | 0 |
- Anual
- Trimestral
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total Activo Corriente | 165 | 85.121 | 124.067 | 113.344 | 97.864 |
Efectivo e inversiones a corto plazo | 161.171 | 82.188 | 121.761 | 110.83 | 94.313 |
Efectivo y Equivalentes | 34.012 | 22.88 | 49.804 | 24.301 | 22.121 |
Total deudores, neto | 1.144 | 1.695 | 1.617 | 1.684 | 1.03 |
Prepaid Expenses | 2.329 | 1.044 | 0.431 | 0.723 | 2.287 |
Other Current Assets, Total | 0.356 | 0.194 | 0.258 | 0.107 | 0.234 |
Total Assets | 176.598 | 97.745 | 136.203 | 152.287 | 159.628 |
Property/Plant/Equipment, Total - Net | 0.373 | 0.356 | 1.025 | 0.522 | 0.925 |
Goodwill, Net | 26.918 | 27.082 | |||
Intangibles, Net | 11.274 | 12.218 | 11.111 | 11.372 | 33.626 |
Other Long Term Assets, Total | -0.049 | 0.05 | 0.131 | 0.131 | |
Total Current Liabilities | 14.66 | 8.174 | 10.88 | 7.254 | 6.015 |
Accounts Payable | 1.443 | 2.595 | 3.409 | 3.879 | 2.784 |
Accrued Expenses | 4.884 | 5.579 | 5.471 | 3.058 | 2.966 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 8.333 | 2 | 0.041 | 0.265 | |
Total Liabilities | 32.1 | 33.362 | 34.505 | 44.068 | 40.319 |
Total Long Term Debt | 17.323 | 25.104 | 23.112 | 24.53 | 15.072 |
Long Term Debt | 17.323 | 25.104 | 23.112 | 24.53 | 14.775 |
Capital Lease Obligations | 0 | 0.297 | |||
Deferred Income Tax | 0 | 7.181 | |||
Other Liabilities, Total | 0.117 | 0.084 | 0.513 | 12.284 | 12.051 |
Total Equity | 144.498 | 64.383 | 101.698 | 108.219 | 119.309 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
Common Stock | 0.116 | 0.055 | 0.052 | 0.036 | 0.032 |
Additional Paid-In Capital | 444.898 | 320.893 | 309.555 | 237.702 | 186.522 |
Retained Earnings (Accumulated Deficit) | -300.521 | -257.507 | -207.892 | -129.719 | -68.203 |
Other Equity, Total | 0.054 | 0.942 | -0.017 | 0.2 | 0.958 |
Total Liabilities & Shareholders’ Equity | 176.598 | 97.745 | 136.203 | 152.287 | 159.628 |
Total Common Shares Outstanding | 114.037 | 54.153 | 50.7904 | 35.1461 | 30.5095 |
Total Preferred Shares Outstanding | 0 | ||||
Inversiones a corto plazo | 127.159 | 59.308 | 71.957 | 86.529 | 72.192 |
Property/Plant/Equipment, Total - Gross | 2.452 | 2.329 | 2.699 | 1.89 | 1.776 |
Accumulated Depreciation, Total | -2.079 | -1.973 | -1.674 | -1.368 | -0.851 |
Other Current Liabilities, Total | 0 | 0.276 | |||
Unrealized Gain (Loss) | -0.049 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total Activo Corriente | 154.537 | 165 | 174.584 | 183.488 | 194.802 |
Efectivo e inversiones a corto plazo | 151.797 | 161.171 | 170.806 | 180.671 | 192.713 |
Efectivo y Equivalentes | 79.227 | 34.012 | 44.699 | 40.653 | 55.982 |
Inversiones a corto plazo | 72.57 | 127.159 | 126.107 | 140.018 | 136.731 |
Total deudores, neto | 1.149 | 1.144 | 1.207 | 1.462 | 1.423 |
Prepaid Expenses | 1.285 | 2.329 | 2.439 | 1.167 | 0.445 |
Other Current Assets, Total | 0.306 | 0.356 | 0.132 | 0.188 | 0.221 |
Total Assets | 166.209 | 176.598 | 187.274 | 196.433 | 207.63 |
Property/Plant/Equipment, Total - Net | 0.064 | 0.073 | 0.091 | 0.102 | 0.124 |
Intangibles, Net | 11.06 | 11.274 | 11.547 | 11.834 | 11.676 |
Other Long Term Assets, Total | 0.548 | 0.251 | 1.052 | 1.009 | 1.028 |
Total Current Liabilities | 16.323 | 14.66 | 10.661 | 5.635 | 7.207 |
Accounts Payable | 1.296 | 1.443 | 1.279 | 2.144 | 2.723 |
Accrued Expenses | 2.527 | 4.884 | 5.215 | 3.491 | 4.484 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 29.734 | 32.1 | 32.045 | 31.051 | 32.509 |
Total Long Term Debt | 13.309 | 17.323 | 21.35 | 25.381 | 25.244 |
Long Term Debt | 13.309 | 17.323 | 21.35 | 25.381 | 25.244 |
Other Liabilities, Total | 0.102 | 0.117 | 0.034 | 0.035 | 0.058 |
Total Equity | 136.475 | 144.498 | 155.229 | 165.382 | 175.121 |
Common Stock | 0.116 | 0.116 | 0.115 | 0.114 | 0.114 |
Additional Paid-In Capital | 445.471 | 444.898 | 444.04 | 443.341 | 442.246 |
Retained Earnings (Accumulated Deficit) | -308.821 | -300.521 | -289.211 | -278.665 | -267.724 |
Unrealized Gain (Loss) | -0.137 | -0.049 | -0.011 | -0.001 | -0.025 |
Other Equity, Total | -0.154 | 0.054 | 0.296 | 0.593 | 0.51 |
Total Liabilities & Shareholders’ Equity | 166.209 | 176.598 | 187.274 | 196.433 | 207.63 |
Total Common Shares Outstanding | 114.041 | 114.037 | 113.867 | 113.848 | 113.579 |
Current Port. of LT Debt/Capital Leases | 12.5 | 8.333 | 4.167 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -38.15 | -43.014 | -49.615 | -78.173 | -61.516 |
Efectivo de actividades de explotación | -34.554 | -40.081 | -39.836 | -45.123 | -39.275 |
Efectivo de actividades de explotación | 0.031 | 0.136 | 0.255 | 1.01 | 0.526 |
Deferred Taxes | -7.057 | ||||
Partidas no monetarias | 2.605 | 5.643 | 11.229 | 31.193 | 26.326 |
Intereses pagados en efectivo | 1.614 | 1.969 | 2.47 | 2.099 | 1.406 |
Cambios en el capital circulante | 0.96 | -2.846 | -1.705 | 0.847 | 2.446 |
Efectivo de actividades de inversión | 52.645 | -69.456 | 9.053 | 15.74 | -13.619 |
Gastos de capital | -0.009 | -0.057 | -3.294 | -0.148 | -0.141 |
Otras partidas de flujo de caja de inversión, total | 52.654 | -69.399 | 12.347 | 15.888 | -13.478 |
Efectivo procedente de actividades de financiación | 0.087 | 120.806 | 3.689 | 54.908 | 55.193 |
Elementos de flujo de caja de financiación | -0.003 | -0.078 | |||
Emisión (retiro) de acciones, neto | 0.002 | 120.884 | 4.203 | 54.949 | 46.374 |
Emisión (amortización) de deuda, neta | 0.088 | 0 | -0.514 | -0.041 | 8.819 |
Variación neta de la tesorería | 18.088 | 11.132 | -26.924 | 25.503 | 2.18 |
Efectos del cambio de divisas | -0.09 | -0.137 | 0.17 | -0.022 | -0.119 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -38.15 | -27.85 | -17.464 | -8.3 | -43.014 |
Cash From Operating Activities | -34.554 | -25.903 | -17.741 | -8.425 | -40.081 |
Cash From Operating Activities | 0.031 | 0.024 | 0.016 | 0.008 | 0.136 |
Non-Cash Items | 2.605 | 2.258 | 1.636 | 1.04 | 5.643 |
Cash Interest Paid | 1.614 | 1.186 | 0.857 | 0.484 | 1.969 |
Changes in Working Capital | 0.96 | -0.335 | -1.929 | -1.173 | -2.846 |
Cash From Investing Activities | 52.645 | 111.856 | 78.86 | 53.665 | -69.456 |
Capital Expenditures | -0.009 | -0.009 | -0.005 | -0.057 | |
Other Investing Cash Flow Items, Total | 52.654 | 111.865 | 78.865 | 53.665 | -69.399 |
Cash From Financing Activities | 0.087 | 0.086 | 0.087 | -0.001 | 120.806 |
Issuance (Retirement) of Stock, Net | 0.002 | 0 | 0 | 0 | 120.884 |
Issuance (Retirement) of Debt, Net | 0.088 | 0.088 | 0.088 | 0 | |
Foreign Exchange Effects | -0.09 | -0.21 | -0.065 | -0.024 | -0.137 |
Net Change in Cash | 18.088 | 85.829 | 61.141 | 45.215 | 11.132 |
Financing Cash Flow Items | -0.003 | -0.002 | -0.001 | -0.001 | -0.078 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
New Enterprise Associates (NEA) | Venture Capital | 21.1655 | 24137931 | 0 | 2022-12-31 | LOW |
Bain Capital Life Sciences Investors, LLC | Investment Advisor | 10.1913 | 11622598 | 0 | 2022-12-31 | LOW |
Farallon Capital Management, L.L.C. | Hedge Fund | 8.8869 | 10134961 | 226875 | 2022-12-31 | MED |
Caxton Associates LP | Hedge Fund | 6.0473 | 6896551 | 0 | 2022-12-31 | HIGH |
Adage Capital Management, L.P. | Hedge Fund | 6.0192 | 6864551 | 0 | 2022-12-31 | LOW |
VR Adviser, LLC | Venture Capital | 5.5694 | 6351531 | 164249 | 2022-12-31 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.2147 | 4806573 | 1527 | 2022-12-31 | LOW |
AXA Investment Managers UK Ltd. | Investment Advisor/Hedge Fund | 2.9882 | 3407887 | -18328 | 2022-12-31 | MED |
Ramsay (David A) | Individual Investor | 1.8424 | 2101142 | 154890 | 2022-12-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.8985 | 1024702 | 5639 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8902 | 1015212 | 3993 | 2022-12-31 | LOW |
Sio Capital Management, LLC | Hedge Fund | 0.7597 | 866448 | 10020 | 2022-12-31 | HIGH |
Pauls Matthew | Individual Investor | 0.5668 | 646354 | 325000 | 2022-12-13 | MED |
UBS O'Connor LLC | Hedge Fund | 0.3958 | 451441 | 70611 | 2022-12-31 | HIGH |
Bridgeway Capital Management, LLC | Investment Advisor | 0.3392 | 386793 | 0 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.235 | 268011 | -3600 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.2308 | 263187 | -19124 | 2022-12-31 | HIGH |
QS Investors, LLC_NLE | Investment Advisor/Hedge Fund | 0.2135 | 243500 | 239500 | 2021-06-30 | LOW |
Susquehanna International Group, LLP | Investment Advisor | 0.1721 | 196242 | 128898 | 2022-12-31 | MED |
Franklin Advisers, Inc. | Investment Advisor/Hedge Fund | 0.1612 | 183880 | 0 | 2022-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group500K+
Traders
92K+
Clientes activos mensualmente
$53M+
Volumen mensual de inversión
$30M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Savara Company profile
Sobre Savara Inc
Savara Inc. es una empresa en fase clínica. La empresa se centra en las enfermedades respiratorias raras. El programa principal de la empresa, la solución nebulizadora de molgramostim (molgramostim), es un factor estimulante de colonias de granulocitos-macrófagos inhalado que se encuentra en fase III de desarrollo para la proteinosis alveolar pulmonar autoinmune (aPAP). Molgramostim, una formulación inhalada de GM-CSF humano recombinante, se está desarrollando para el tratamiento de la aPAP. La proteinosis alveolar pulmonar (PAP) es una rara enfermedad pulmonar caracterizada por la acumulación de surfactante en los alvéolos o sacos de aire de los pulmones.
Industry: | Bio Therapeutic Drugs |
6836 Bee Cave Road
Building 3, Suite 201
AUSTIN
TEXAS 78746
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com